Medifast: 3 Key Takeaways for Long-Term Investors

Medifast reported Q3 2026 revenue of $72 million with a strategic pivot toward metabolic health products. The company reduced its active coach count to 10.2 thousand but increased average revenue per coach by 54% through compensation restructuring. Cost-cutting initiatives and a debt-free balance sheet with $172.5 million in cash provide runway for growth, with management targeting Q4 2026 profitability.